Panax Ginseng for Cognitive Function

Verdict: Weak, disputed evidence for cognition

Panax ginseng is not a proven cognitive enhancer. The best evidence shows at most a small, inconsistent signal limited to memory, with no benefit for overall cognition, attention, or executive function.

C 🟠 C Weak Evidence Disputed

🔬Why this grade7-layer evidence engine

The grade is held to Weak (Tier C, Disputed) because the highest-quality evidence does not support a broad nootropic effect. A 2010 Cochrane systematic review (PMID 21154383) of 9 RCTs could not pool data due to heterogeneity in outcomes, dose, and duration, and concluded there is no convincing evidence of cognitive enhancement in healthy adults and no high-quality evidence in dementia. A 2024 meta-analysis (PMID 39474788, 15 RCTs, 671 participants) found a significant effect only for memory (SMD 0.19, larger at high doses, SMD 0.33), with no benefit for overall cognition, attention, or executive function.

Supportive signals come only from individual trials on isolated measures: a 2019 RCT in mild cognitive impairment (PMID 32055589) improved one memory subtest, and a 2025 RCT (PMID 40289951) improved a single CANTAB planning task, but it was industry-funded by a ginseng producer. These narrow, dose-dependent results do not amount to a reliable cognitive benefit.

Regulators and clinics reinforce the cautious grade. The FDA issues no approved cognitive claim (it ceased evaluating the relevant notice); the UK NHS notes herbal products are not tested like standard medicines and warns of interactions; and Harvard Health is negative. WHO records only a traditional tonic use, not trial-grade endorsement. Ginseng also carries interaction risks (warfarin, blood-glucose-lowering drugs), so high-dose self-supplementation for brain benefits is not advisable.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.56
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Disputed
Confidence
60%
Conflicting evidence
Evidence level
E1
Cochrane high-quality SR/MA

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.35
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
L2 PubMedPrimary literature
0.60
L3 MechanismPlausibility
0.75
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.555
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 0 negative)
  4. tier_strict_requirement_check — | B→C 因 scope.conflation_risk=true 且 L11 獨評較低 (B7-2 tier cap)
  5. detect_disputes — 偵測到 1 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Ginseng for cognition
PMID: 21154383 2010 Cochrane SR
Finding: Cochrane review of 9 eligible RCTs (5 with extractable data; 8 in healthy adults, 1 in age-associated memory impairment) found improvement in some aspects of cognitive function, behaviour and quality of life and no serious adverse events, but data pooling was impossible due to heterogeneity in outcome measures, dose and trial duration; the authors concluded there is a lack of convincing evidence for a cognitive-enhancing effect of Panax ginseng in healthy participants and no high-quality evidence in dementia.
🟢 High quality
View on PubMed
Effects of Ginseng on Cognitive Function: A Systematic Review and Meta-Analysis
PMID: 39474788 2024 統合分析 n = 671
Finding: Meta-analysis of 15 RCTs (671 participants spanning healthy adults, cognitive impairment, schizophrenia, hospitalized patients and Alzheimer's disease) found ginseng significantly improved memory (SMD 0.19, 95% CI 0.02-0.36, p<0.05), with a larger effect at high doses (SMD 0.33, 95% CI 0.04-0.61, p<0.05); no significant benefit was seen for overall cognition (SMD 0.06, p=0.86), attention (SMD 0.06, p=0.54) or executive function (SMD -0.03, p=0.79).
🟢 High quality Effect size: [object Object]
View on PubMed
Cognition enhancing effect of panax ginseng in Korean volunteers with mild cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial
PMID: 32055589 2019 RCT (double-blind) n = 90
Finding: In 90 Korean volunteers with mild cognitive impairment, 3 g/day Panax ginseng powder for 6 months significantly improved RCFT immediate recall versus placebo (p=0.0405 per-protocol, p=0.0342 intention-to-treat), suggesting a cognition-enhancing effect, though other SNSB domains did not reach significance.
View on PubMed
Effect of Hydroponically Grown Red Panax Ginseng on Perceived Stress, Emotional Processing and Cognitive Functions in Moderately Stressed Adults
PMID: 40289951 2025 RCT (double-blind) n = 149
Finding: In 149 moderately stressed adults, 200 mg/day Red Panax ginseng for 3 weeks reduced perceived stress (PSS -4.3 vs -2.7, p=0.040) and negative affect (PANAS, p=0.032), and improved one cognitive measure - faster spatial planning response latency on the CANTAB OTSC task (-1633 ms, p=0.002); the supplement was well tolerated.
⚠️ Industry-funded Effect size: [object Object]
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Neutral
FDA ceased to evaluate this notice source↗
L4b EU EFSA
Cautious
L4c UK NHS
Cautious
Herbal medicines are not available on the NHS. ... Herbal medicines are not tested in the same way as standard medicines to see how well they work. ... Always check first with a pharmacist before taking a herbal medicine, if you're already taking other medicine. ... Only use herbal products with a traditional herbal registration (THR) mark and a product code from the Medicines and Healthcare pr… source↗
L4d TW TFDA / 衛福部
Neutral
人參為五加科植物人參(Panax ginseng C.A. Meyer)的乾燥根。人參茶包所含有之原料人參,應符合中藥藥材污穢物質限量之規定,總重金屬限量為20ppm、砷2ppm、總BHC 0.9ppm、總DDT 1.0ppm及PCNB 1.0ppm。 source↗
L4e WHO
Supportive
Radix Ginseng [the dried root of Panax ginseng C.A. Meyer] is used as a prophylactic and restorative agent for enhancement of mental and physical capacities, in cases of weakness, exhaustion, tiredness, and loss of concentration, and during convalescence. The recommended dosage is 0.5-2 g of dried root per day; there are no contraindications regarding ginseng. source↗
L5a NIH Office of Dietary Supplements
Cautious
L5c Cleveland Clinic
Neutral
L5d Harvard Health
Against
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-cognitive-function-INT-panax-ginseng-001 繁體中文版 →